Westlake today announced the launch of its third fund of $450 million to incubate and grow early stage next-generation biotechnology companies in the Los Angeles region and beyond. The new fund will be managed by founding managing director Beth Seidenberg, M.D., managing director Mira Chaurushiya, Ph.D., and David Allison, Ph.D., who was recently appointed managing director.
Mira Chaurushiya, Managing Director at Westlake Village BioPartners, has been named one of Endpoints News’ LGBTQ+ biopharma leaders for 2023.
On May 19, Westlake Village BioPartners was named Business of the Year by the Greater Conjeo Valley Chamber of Commerce. We’re honored to be a part of the vibrancy and sustainability of the economic, cultural and philanthropic landscape of the Conejo Valley.
Three scientists from Westlake-founded companies have made this year’s Endpoints Top 20 Scientists Under 40 list. Meet Sharif Tabebordbar, Nick Goeden,
Westlake’s co-founding managing director, Beth Seidenberg, MD, was profiled in the cover story of this month’s edition of Pharmaceutical Executive.
The Healthcare Businesswomen’s Association (HBA) announced Westlake’s Beth Seidenberg as the 2022 Woman of the Year. She was recognized for her significant contributions to healthcare and the advancement of women in the industry.
Westlake today announced the appointment of Mira Chaurushiya, Ph.D., to the position of senior partner. Dr. Chaurushiya will be a full investing partner at Westlake. She joins the firm from 5AM Ventures, where she spent more than six years growing and building next-generation life sciences companies.
Westlake continues to be a catalyst for the Los Angeles Biotech Hub, bringing expertise and capital to the region as
Westlake’s co-founding managing director Beth Seidenberg was named by Barron’s as one of the “100 Most Influential Women in U.S. Finance” as part of its second annual list that honors women who are helping lead and shape the modern financial-services industry.
